MediPlus™ Receives U.S. FDA 510(k) Clearance for Silver Advanced Wound Care Products - MediPurpose
18249
post-template-default,single,single-post,postid-18249,single-format-standard,bridge-core-2.5.9,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-24.4,qode-theme-bridge,disabled_footer_top,qode-wpml-enabled,wpb-js-composer js-comp-ver-7.9,vc_responsive

27 Sep MediPlus™ Receives U.S. FDA 510(k) Clearance for Silver Advanced Wound Care Products

Posted at 16:24h in News, Uncategorized by

ATLANTA, Sept. 27 — MediPurpose, a master distributor and manufacturer of medical products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its MediPlus™ foam wound care products that contain antibacterial silver.

MediPurpose also announced that its expanding MediPlus™ advanced wound care product portfolio now includes Foam Ag, Comfort Foam Ag and Super Foam Ag dressings.

The new foam Ag dressings meet the latest standards for antibacterial control established by the FDA and provide an effective barrier to bacterial penetration. The silver foam dressings are indicated for use on a wide range of chronic and traumatic wounds that included ulcers (arterial, diabetic and venous), pressure sores, donor sites, surgical incisions/excisions and first- and second-degree burns.

Product is expected to be available in the fourth quarter, and information for requesting pricing and samples is available online.

“The addition of these silver foam advanced wound care products to our portfolio is an exciting development,” said MediPurpose Vice President Wound Care Michael Riddle.

“Our ability to provide cost effective wound care solutions is an integral part of MediPurpose’s value proposition,” added Riddle. “We can now supply a range of antibacterial dressings at prices that will allow healthcare professionals to offer these beneficial products to a larger population of patients.”

MediPlus™ enjoyed two successful debuts earlier this year at the 24th Annual Symposium on Advanced Wound Care and at the 43rd Wound, Ostomy and Continence Nurse Society Conference (WOCN).

“We have been very pleased with the number of positive comments we’ve received about the depth of our advanced wound care product portfolio, its competitive nature and the acknowledgement that our value-based pricing should position us for success in today’s cost-conscious environment,” said Riddle.

The MediPlus advanced wound care product line currently features:

* Foams: MediPlus Foam, MediPlus Comfort Foam, MediPlus Super Foam, MediPlus HC Foam
* Hydrocolloids: MediPlus HC (Standard and Extra-Thin), MediPlus HC Comfort
* Hydrogels: MediPlus Barrier Gel, MediPlus Barrier Gel Comfort
* Non-Adherent Pads: MediPlus PE Pad
* Post-Surgical Dressings: MediPlus PU Pad, MediPlus Surgical
* Thin Films: MediPlus PU Film, MediPlus PU Frame

“As an experienced master distributor, MediPurpose has done all the hard work for medical product distributors seeking to purchase high-quality wound care products at competitive prices,” said Riddle.

“MediPlus offers a host of advantages for companies that distribute advanced wound care supplies,” added Riddle. “Our team of experts has completed all the regulatory, quality, reimbursement and logistics required to import the comprehensive line of MediPlus advanced wound care products.”

More information about MediPlus — including no-cost product sample requests — is available at www.medipurpose.com/mediplus.

Print page